EP3013353
CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.6.2014EP published:
21.4.2021EP application number:
14734003.8
EPO information:
European Patent Register
Max expiry date:
25.6.2034
Title:
CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY FOR THE TREATMENT OF CYSTITIS
Timeline
Today
26.6.2014EP application
21.4.2021EP Publication
Owner
Name:
Xigen Inflammation Ltd.Address:
Arch. Makariou III 195 Neocleous House, 3030 Limassol, CY
Inventor
Name:
COMBETTE, Jean-MarcAddress:
74140 Saint Cergues, FR
Name:
DELOCHE, CatherineAddress:
CH-1207 Genf, CH
Priority
Number:
PCT/EP2013/001881Date:
26.6.2013Country:
WO
Number:
PCT/EP2013/001896Date:
27.6.2013Country:
WO
Classification
Categories:
A61K 38/17, C07K 14/47, A61K 48/00, C07K 16/40, C12N 15/00, A61P 25/28, A61P 3/10, A61P 41/00, A61P 13/12, A61K 38/55, A61P 1/00, A61P 1/02, A61P 1/04, A61P 1/16, A61P 1/18, A61P 3/00, A61P 3/08, A61P 5/00